CTSO
Cytosorbents CrpNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$37.05M
P/E Ratio
—
EPS
$-0.13
Beta
1.48
52W High
$1.39
52W Low
$0.50
50-Day MA
$0.68
200-Day MA
$0.83
Dividend Yield
—
Profit Margin
-22.10%
Forward P/E
7.20
PEG Ratio
0.00
About Cytosorbents Crp
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
Fundamentals
| Revenue (TTM) | $37.06M |
| Gross Profit (TTM) | $26.49M |
| EBITDA | $-12.72M |
| Operating Margin | -43.90% |
| Return on Equity | -96.40% |
| Return on Assets | -19.40% |
| Revenue/Share (TTM) | $0.60 |
| Book Value | $0.09 |
| Price-to-Book | 6.29 |
| Price-to-Sales (TTM) | 1.00 |
| EV/Revenue | 1.619 |
| EV/EBITDA | -1.92 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 41.60% |
| Shares Outstanding | $62.70M |
| Float | $54.92M |
| % Insiders | 15.63% |
| % Institutions | 27.07% |
Analyst Ratings
Consensus ($5.25 target)
1
Buy1
HoldData last updated: 4/7/2026